Selected research
Industry Research
Cancer Diagnostics Service Industry Research Report 2026
Market perspective
The global Cancer Diagnostics Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Cancer Diagnostics Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Cancer Diagnostics Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Cancer Diagnostics Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Cancer Diagnostics Service include Illumina, BGI Genomics Co.,Ltd., Agilent Technologies, Macrogen, Pacific Biosciences, Abbott, QIAGEN, Siemens Healthcare GmbH and Thermo Fisher Scientific, Inc. and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Cancer Diagnostics Service market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Cancer Diagnostics Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cancer Diagnostics Service Market by Company
Illumina
BGI Genomics Co.,Ltd.
Agilent Technologies
Macrogen
Pacific Biosciences
Abbott
QIAGEN
Siemens Healthcare GmbH
Thermo Fisher Scientific, Inc.
Applied DNA Sciences
Cancer Diagnostics Service Segment by Type
Breast Cancer
Blood Cancer
Lung Cancer
Colorectal Cancer
Ovarian Cancer
Others
Cancer Diagnostics Service Segment by Application
Hospitals
Ambulatory Surgical Centers
Diagnostic Laboratories
Others
Cancer Diagnostics Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cancer Diagnostics Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cancer Diagnostics Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cancer Diagnostics Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Cancer Diagnostics Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Breast Cancer
- Blood Cancer
- Lung Cancer
- Colorectal Cancer
- Ovarian Cancer
- Others
Applications
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Laboratories
- Others
Companies covered
- Illumina
- BGI Genomics Co.,Ltd.
- Agilent Technologies
- Macrogen
- Pacific Biosciences
- Abbott
- QIAGEN
- Siemens Healthcare GmbH
- Thermo Fisher Scientific, Inc.
- Applied DNA Sciences
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Cancer Diagnostics Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Breast Cancer
- 2.2.3 Blood Cancer
- 2.2.4 Lung Cancer
- 2.2.5 Colorectal Cancer
- 2.2.6 Ovarian Cancer
- 2.2.7 Others
- 2.3 Cancer Diagnostics Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospitals
- 2.3.3 Ambulatory Surgical Centers
- 2.3.4 Diagnostic Laboratories
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Cancer Diagnostics Service Breakdown Data by Type
- 3.1 Global Cancer Diagnostics Service Historic Market Size by Type (2021-2026)
- 3.2 Global Cancer Diagnostics Service Forecasted Market Size by Type (2027-2032)
4 Cancer Diagnostics Service Breakdown Data by Application
- 4.1 Global Cancer Diagnostics Service Historic Market Size by Application (2021-2026)
- 4.2 Global Cancer Diagnostics Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Cancer Diagnostics Service Market Perspective (2021-2032)
- 5.2 Global Cancer Diagnostics Service Growth Trends by Region
- 5.2.1 Global Cancer Diagnostics Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Cancer Diagnostics Service Historic Market Size by Region (2021-2026)
- 5.2.3 Cancer Diagnostics Service Forecasted Market Size by Region (2027-2032)
- 5.3 Cancer Diagnostics Service Market Dynamics
- 5.3.1 Cancer Diagnostics Service Industry Trends
- 5.3.2 Cancer Diagnostics Service Market Drivers
- 5.3.3 Cancer Diagnostics Service Market Challenges
- 5.3.4 Cancer Diagnostics Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Cancer Diagnostics Service Players by Revenue
- 6.1.1 Global Top Cancer Diagnostics Service Players by Revenue (2021-2026)
- 6.1.2 Global Cancer Diagnostics Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Cancer Diagnostics Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Cancer Diagnostics Service Head Office and Area Served
- 6.4 Global Cancer Diagnostics Service Players, Product Type & Application
- 6.5 Global Cancer Diagnostics Service Manufacturers Established Date
- 6.6 Global Cancer Diagnostics Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Cancer Diagnostics Service Market Size (2021-2032)
- 7.2 North America Cancer Diagnostics Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Cancer Diagnostics Service Market Size by Country (2021-2026)
- 7.4 North America Cancer Diagnostics Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Cancer Diagnostics Service Market Size (2021-2032)
- 8.2 Europe Cancer Diagnostics Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Cancer Diagnostics Service Market Size by Country (2021-2026)
- 8.4 Europe Cancer Diagnostics Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Cancer Diagnostics Service Market Size (2021-2032)
- 9.2 Asia-Pacific Cancer Diagnostics Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Cancer Diagnostics Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Cancer Diagnostics Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Cancer Diagnostics Service Market Size (2021-2032)
- 10.2 South America Cancer Diagnostics Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Cancer Diagnostics Service Market Size by Country (2021-2026)
- 10.4 South America Cancer Diagnostics Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Cancer Diagnostics Service Market Size (2021-2032)
- 11.2 Middle East & Africa Cancer Diagnostics Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Cancer Diagnostics Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Cancer Diagnostics Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Illumina
- 12.1.1 Illumina Company Information
- 12.1.2 Illumina Business Overview
- 12.1.3 Illumina Revenue in Cancer Diagnostics Service Business (2021-2026)
- 12.1.4 Illumina Cancer Diagnostics Service Product Portfolio
- 12.1.5 Illumina Recent Developments
- 12.2 BGI Genomics Co.,Ltd.
- 12.2.1 BGI Genomics Co.,Ltd. Company Information
- 12.2.2 BGI Genomics Co.,Ltd. Business Overview
- 12.2.3 BGI Genomics Co.,Ltd. Revenue in Cancer Diagnostics Service Business (2021-2026)
- 12.2.4 BGI Genomics Co.,Ltd. Cancer Diagnostics Service Product Portfolio
- 12.2.5 BGI Genomics Co.,Ltd. Recent Developments
- 12.3 Agilent Technologies
- 12.3.1 Agilent Technologies Company Information
- 12.3.2 Agilent Technologies Business Overview
- 12.3.3 Agilent Technologies Revenue in Cancer Diagnostics Service Business (2021-2026)
- 12.3.4 Agilent Technologies Cancer Diagnostics Service Product Portfolio
- 12.3.5 Agilent Technologies Recent Developments
- 12.4 Macrogen
- 12.4.1 Macrogen Company Information
- 12.4.2 Macrogen Business Overview
- 12.4.3 Macrogen Revenue in Cancer Diagnostics Service Business (2021-2026)
- 12.4.4 Macrogen Cancer Diagnostics Service Product Portfolio
- 12.4.5 Macrogen Recent Developments
- 12.5 Pacific Biosciences
- 12.5.1 Pacific Biosciences Company Information
- 12.5.2 Pacific Biosciences Business Overview
- 12.5.3 Pacific Biosciences Revenue in Cancer Diagnostics Service Business (2021-2026)
- 12.5.4 Pacific Biosciences Cancer Diagnostics Service Product Portfolio
- 12.5.5 Pacific Biosciences Recent Developments
- 12.6 Abbott
- 12.6.1 Abbott Company Information
- 12.6.2 Abbott Business Overview
- 12.6.3 Abbott Revenue in Cancer Diagnostics Service Business (2021-2026)
- 12.6.4 Abbott Cancer Diagnostics Service Product Portfolio
- 12.6.5 Abbott Recent Developments
- 12.7 QIAGEN
- 12.7.1 QIAGEN Company Information
- 12.7.2 QIAGEN Business Overview
- 12.7.3 QIAGEN Revenue in Cancer Diagnostics Service Business (2021-2026)
- 12.7.4 QIAGEN Cancer Diagnostics Service Product Portfolio
- 12.7.5 QIAGEN Recent Developments
- 12.8 Siemens Healthcare GmbH
- 12.8.1 Siemens Healthcare GmbH Company Information
- 12.8.2 Siemens Healthcare GmbH Business Overview
- 12.8.3 Siemens Healthcare GmbH Revenue in Cancer Diagnostics Service Business (2021-2026)
- 12.8.4 Siemens Healthcare GmbH Cancer Diagnostics Service Product Portfolio
- 12.8.5 Siemens Healthcare GmbH Recent Developments
- 12.9 Thermo Fisher Scientific, Inc.
- 12.9.1 Thermo Fisher Scientific, Inc. Company Information
- 12.9.2 Thermo Fisher Scientific, Inc. Business Overview
- 12.9.3 Thermo Fisher Scientific, Inc. Revenue in Cancer Diagnostics Service Business (2021-2026)
- 12.9.4 Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Product Portfolio
- 12.9.5 Thermo Fisher Scientific, Inc. Recent Developments
- 12.10 Applied DNA Sciences
- 12.10.1 Applied DNA Sciences Company Information
- 12.10.2 Applied DNA Sciences Business Overview
- 12.10.3 Applied DNA Sciences Revenue in Cancer Diagnostics Service Business (2021-2026)
- 12.10.4 Applied DNA Sciences Cancer Diagnostics Service Product Portfolio
- 12.10.5 Applied DNA Sciences Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst